C1QTNF9 and myocardial infarction: CTRP9 reduces myocardial infarct size and cardiomyocyte apoptosis following ischemia-reperfusion, improves cardiac function in diabetic mice and attenuates adverse cardiac remodeling after myocardial infarction.